How Cerebral Infarction Medications Work

Cerebral infarction, commonly known as a stroke, occurs when the blood supply to the brain is interrupted, leading to tissue damage and loss of function. The primary goal of medication treatment for cerebral infarction is to restore blood flow to the affected area.

Gold Standard: Thrombolysis (e.g., tPA)

The gold standard for treating acute ischemic stroke is thrombolysis, which involves administering tissue plasminogen activator (tPA) to dissolve the clot and restore blood flow. This treatment is most effective when administered within 3-4.5 hours of symptom onset.

Alternatives and Adjunctive Therapies

• Endovascular thrombectomy: A minimally invasive procedure that involves removing the clot using a catheter, often used in conjunction with tPA or as an alternative for patients who are not candidates for thrombolysis.
• Heparin anticoagulation therapy: Administered to prevent further clot formation and promote blood flow, often used in combination with other treatments.
• Antiplatelet therapy (e.g., aspirin or clopidogrel): Used to reduce the risk of recurrent stroke by preventing platelets from aggregating and forming new clots.

These medications work by either dissolving existing clots, preventing new clot formation, or promoting blood flow to the affected area. Early administration is critical in minimizing tissue damage and improving outcomes for patients with cerebral infarction.